SBC Medical Group Q4 Earnings Call Highlights

2 hours ago 3

MarketBeat

Fri, March 27, 2026 astatine 9:07 AM CDT 7 min read

SBC Medical Group logo

Clinic-level recovery: SBC ended December 2025 with 283 locations and 6.63 cardinal customers, with full session gross of $1,163M (+2% YoY) and mean gross per lawsuit rising to $316 (+11% YoY), indicating improving portion economics and a imaginable inflection point.
Mixed financials: Full-year gross fell to $174M (‑15% YoY) mostly owed to 2024 restructuring and interest changes, but profitability improved—net income roseate 9% to $51M, EPS to $0.50, and EBITDA was $70M with a 40.4% margin.
Strategic pivot to longevity and AI: Management is prioritizing longevity-focused services (SBC Wellness 2.0), broader AI-driven healthcare tools, a multi-brand dermatology attack and targeted M&A/overseas partnerships (e.g., OrangeTwist, BLEZ ASIA) to thrust semipermanent growth.
Interested successful SBC Medical Group Holdings Incorporated? Here are 5 stocks we similar better.

SBC Medical Group (NASDAQ:SBC) utilized its fiscal 2025 full-year results briefing to outline signs of improving clinic-level economics, sermon the interaction of caller restructuring connected reported revenue, and item a strategy centered connected longevity-focused healthcare and expanded usage of artificial intelligence.

CEO Yoshiyuki Aikawa said the institution ended December 2025 with 283 locations and reported 6.63 cardinal customers served implicit the trailing 12 months. While same-store income were “slightly below” the anterior year, helium said total session gross for the afloat twelvemonth reached $1,163 million, representing 2% year-over-year growth.

→ Microsoft’s Next AI Leg: Can MSFT Still Outperform From Here?

Aikawa highlighted a rebound successful portion economics precocious successful the year. Average gross per customer, which absorption said had been connected a declining trend, accrued successful the 4th fourth to $316, up 11% year-over-year. He said the institution is present seeing lawsuit maturation and improving portion economics “moving successful the aforesaid direction,” which absorption views arsenic a affirmative indicator for the business.

He besides pointed to a dependable quarterly betterment successful mean gross per sojourn and said full session gross has begun to bespeak an upward trajectory. If the inclination continues, helium said the institution believes it could correspond an inflection constituent for semipermanent growth.

→ Is 2026 the Year of Space Stocks? 2 Stocks to Watch

Management described a scope of developments during fiscal 2025, including efforts to deepen the home level and instrumentality aboriginal steps internationally.

Domestic initiatives: Aikawa cited betterment successful lawsuit spending, continued enlargement of the dermatology lawsuit base, constitution of what helium described arsenic the largest AGA hairsbreadth nonaccomplishment attraction web successful Japan, and enlargement successful orthopedics and fertility treatment.
Platform additions: The institution referenced the opening of NEO Skin Clinic and Hadano Aozora Clinic, the joining of JUN CLINIC, and the consolidation of Waqoo done a tender offer.
International steps: Management said it made a strategical concern successful OrangeTwist successful the U.S. and formed a concern with BLEZ ASIA successful Thailand.